DEFENCATH
These highlights do not include all the information needed to use DEFENCATH safely and effectively. See full prescribing information for DEFENCATH. DEFENCATH (taurolidine and heparin) catheter lock solution, for central venous catheter instillation useInitial U.S. Approval: 2023LIMITED POPULATION
13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6
HUMAN PRESCRIPTION DRUG LABEL
Dec 21, 2023
CorMedix Inc.
DUNS: 849818831
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
taurolidine and heparin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
taurolidine and heparin
Product Details
FDA regulatory identification and product classification information